Treatment of diseases mediated by the nitric oxide/cGMP/protein kinase G pathway
US5990177A · kind A · utility
31Cited by
1References
20Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Sep 18, 1997 |
| Grant date | Nov 23, 1999 |
| Priority date | — |
| Expiry date | Sep 18, 2017 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P25/28
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Disclosed are methods and compositions for stimulating cellular nitric oxide (NO) synthesis, cyclic guanosine monophosphate levels (cGMP), and protein kinase G (PKG) activity for purposes of treating diseases mediated by deficiencies in the NO/cGMP/PKG signal transduction pathway, by administration of various compounds including alcohols, diols and/or triols and their analogues.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.